@prefix rr: <http://www.w3.org/ns/r2rml#>.
# ["Clinical Annotation ID","Location","Gene","Level of Evidence","Clinical Annotation Types","Genotype-Phenotype IDs","Annotation Text","Variant Annotations IDs","Variant Annotations","PMIDs","Evidence Count","Related Chemicals","Related Diseases","Race","Chromosome"]
# ["981755803","rs75527207","CFTR (PA109)","1A","Efficacy","1449192741\",\"1449192742\",\"1449192743","AA:Ivacaftor is indicated in cystic fibrosis patients with the AA genotype (two copies of the CFTR G551D variant). FDA-approved drug labeling information indicates use of ivacaftor in cystic fibrosis patients with at least one copy of a list of 33 CFTR genetic variants, including G551D. Other genetic and clinical factors may also influence a patient's response to ivacaftor.\",\"AG:Ivacaftor is indicated in cystic fibrosis patients with the AG genotype (one copy of the CFTR G551D variant). FDA-approved drug labeling information indicates use of ivacaftor in cystic fibrosis patients with at least one copy of a list of 33 CFTR genetic variants, including G551D. Other genetic and clinical factors may also influence a patient's response to ivacaftor.\",\"GG:Indication of ivacaftor in cystic fibrosis patients with the GG genotype (no copies of the CFTR G551D variant) is dependent on the presence of other variants within the CFTR gene. FDA-approved drug labeling information indicates use of ivacaftor in cystic fibrosis patients with at least one copy of a list of 33 CFTR genetic variants, including G551D. Other genetic and clinical factors may also influence a patient's response to ivacaftor. ","981755665\",\"981755678\",\"981755699\",\"981755746\",\"981755787\",\"982006840\",\"982009991\",\"1043737597\",\"1043737620\",\"1043737636\",\"1183629335\",\"1448267532\",\"1448423752\",\"1449191908\",\"1449192031\",\"1449192055\",\"1449192093\",\"1449192439\",\"1449192481\",\"1449192494\",\"1449192546\",\"1449192576\",\"1449192615\",\"1449192709\",\"1449192721\",\"1184512440\",\"1446903789\",\"1448099051","Genotypes AA + AG are associated with response to ivacaftor in people with Cystic Fibrosis.\",\"Genotypes AA + AG are associated with response to ivacaftor in people with Cystic Fibrosis.\",\"Allele A is associated with response to ivacaftor.\",\"Allele A is associated with response to ivacaftor.\",\"Allele A  is associated with  response to ivacaftor.\",\"Allele A is associated with response to ivacaftor in men with Cystic Fibrosis.\",\"Allele A is associated with response to ivacaftor in children with Cystic Fibrosis.\",\"Allele A is associated with response to ivacaftor in people with Cystic Fibrosis.\",\"Allele A is associated with increased activity of CFTR when treated with ivacaftor in transfected CHO cells.\",\"Allele A  is associated with  activity of CFTR when treated with ivacaftor in FRT cell lines.\",\"Genotype AA is associated with response to ivacaftor in women with Cystic Fibrosis.\",\"Genotypes AA + AG  is associated with  decreased severity of bone density when treated with ivacaftor in people with Cystic Fibrosis as compared to genotype GG.\",\"Genotypes AA + AG  is associated with  increased response to ivacaftor in people with Cystic Fibrosis as compared to genotype GG.\",\"Allele A  is associated with  response to ivacaftor in people with Cystic Fibrosis.\",\"Allele A  is associated with  decreased likelihood of cystic fibrosis pulmonary exacerbation when treated with ivacaftor in people with Cystic Fibrosis.\",\"Allele A  is associated with  response to ivacaftor in people with Cystic Fibrosis.\",\"Allele A  is associated with  response to ivacaftor in people with Cystic Fibrosis.\",\"Allele A  is associated with  response to ivacaftor in people with Cystic Fibrosis.\",\"Allele A  is associated with  response to ivacaftor in people with Cystic Fibrosis.\",\"Allele A  is associated with  response to ivacaftor in children with Cystic Fibrosis.\",\"Allele A  is associated with  protein stability of CFTR when treated with ivacaftor.\",\"Allele A  is associated with  response to ivacaftor in people with Cystic Fibrosis.\",\"Allele A  is associated with  response to ivacaftor in people with Cystic Fibrosis.\",\"Allele A  is associated with  response to ivacaftor in people with Cystic Fibrosis.\",\"Allele A  is associated with  response to ivacaftor in people with Cystic Fibrosis.\",\"Allele A  is associated with  response to ivacaftor in people with Cystic Fibrosis.\",\"Genotypes AA + AG  are associated with  response to ivacaftor in people with Cystic Fibrosis.\",\"Genotypes AA + AG  are associated with  increased response to ivacaftor in people with Cystic Fibrosis as compared to genotype GG.","19846789,21083385,22047557,22293084,22942289,23313410,23590265,23757359,23757361,23891399,24066763,24461666,25049054,25145599,25148434,25171465,25311995,25473543,25682022,25755212,26135562,26568242,27158673,27745802,27773592,28611235,28651844,28711222","28","ivacaftor (PA165950341)","Cystic Fibrosis (PA443829)","Mixed Population","chr7"]
# ["981750843","rs8175347","UGT1A1 (PA420)","2A","Toxicity/ADR","1449565276\",\"1449565277\",\"1449565278","(TA)6/(TA)6:Patients with the (TA)6/(TA)6 genotype (i.e. UGT1A1*1/*1) and cancer who are treated with irinotecan-based regimens may have a decreased risk of neutropenia, diarrhea, or asthenia, as compared to patients with the (TA)7/(TA)7 (*28/*28) genotype. Evidence for an association between this genotype and neutropenia is stronger than that for diarrhea or asthenia, and some studies only show significant associations with neutropenia and diarrhea at medium and high doses of the drug (>125 mg/m2). No significant associations have been seen for nausea, mucositis, infection, overall gastrointestinal toxicities (diarrhea, nausea, vomiting, and mucositis combined) or tumor response. One study found a decreased risk of vomiting for this genotype, and another found a decreased risk of treatment-related death, both compared to the (TA)7/(TA)7 genotype. Other genetic and clinical factors may also influence a patient's risk of neutropenia, diarrhea, asthenia, vomiting, or treatment-related death. \",\"(TA)6/(TA)7:Patients with the (TA)6/(TA)7 genotype (i.e. UGT1A1*1/*28) with cancer who are treated with irinotecan-based regimens may have an increased risk of neutropenia, diarrhea, or asthenia, as compared to patients with the (TA)6/(TA)6 (*1/*1) genotype, and a decreased risk compared to those with the (TA)7/(TA)7 (*28/*28) genotype. Evidence for an association between this genotype and neutropenia is stronger than that for diarrhea or asthenia, and some studies only show significant associations with neutropenia at medium and high doses of the drug (>125 mg/m2). No significant associations have been seen for nausea, mucositis, infection, or tumor response. One study found a decreased overall survival time for carriers of the (TA)7 allele. One study found an increased risk of vomiting for this genotype, and another found an increased risk of treatment-related death, both compared to the (TA)6/(TA)6 genotype. Other genetic and clinical factors may also influence a patient's survival time and risk of neutropenia, diarrhea, asthenia, vomiting, or treatment-related death. \",\"(TA)7/(TA)7:Patients with the (TA)7/(TA)7 genotype (i.e. UGT1A1*28/*28) with cancer who are treated with irinotecan-based regimens may have an increased risk of neutropenia, diarrhea, or asthenia, as compared to patients with the (TA)6/(TA)6 (*1/*1) or (TA)6/(TA)7 (*1/*28) genotype. Evidence for an association between this genotype and neutropenia is stronger than that for diarrhea or asthenia, and some studies only show significant associations with neutropenia and diarrhea at medium and high doses of the drug (>125 mg/m2). No significant associations have been seen for nausea, mucositis, infection, overall gastrointestinal toxicities (diarrhea, nausea, vomiting, and mucositis combined), or tumor response. One study found a decreased overall survival time for carriers of the (TA)7 allele. One study found an increased risk of vomiting for this genotype, and another found an increased risk of treatment-related death, both compared to the (TA)6/(TA)6 genotype. Other genetic and clinical factors may also influence a patient's survival time and risk of neutropenia, diarrhea, asthenia, vomiting, or treatment-related death. ","981750428\",\"981750442\",\"981750641\",\"981750671\",\"981755174\",\"981785795\",\"981785922\",\"981785945\",\"981785998\",\"981786003\",\"981786008\",\"981786013\",\"981786018\",\"981786023\",\"981786028\",\"981786033\",\"981786040\",\"981786045\",\"981786057\",\"981792288\",\"981792298\",\"981792303\",\"981792308\",\"981792333\",\"981792338\",\"981792343\",\"981792355\",\"981792360\",\"981792370\",\"981792375\",\"981792380\",\"981794236\",\"981794261\",\"981794302\",\"981794307\",\"981794321\",\"981794471\",\"981794476\",\"981794552\",\"981794556\",\"981802806\",\"981802874\",\"981802887\",\"981802929\",\"981843633\",\"981843639\",\"982023201\",\"982047216\",\"982047222\",\"982047231\",\"827551988\",\"827639056\",\"827639105\",\"827692541\",\"827692543\",\"827692549\",\"827692555\",\"827692559\",\"769169875\",\"769166450\",\"769169872\",\"769169867\",\"769169873\",\"769173335\",\"1184468725\",\"1184468900\",\"1185234664\",\"1185234707\",\"1185234718\",\"1185234729\",\"1185234740\",\"1185234853\",\"1185234861\",\"1185235274\",\"1185235282\",\"1185235301\",\"1185235437\",\"1444698787\",\"1445585016\",\"1447814352\",\"1448617829\",\"1448617837\",\"1448617950\",\"1448617960\",\"1449189268\",\"1449559865\",\"1448617852\",\"1184169627\",\"1184169645\",\"1184483423\",\"1184483429\",\"1184483709\",\"1184510864\",\"1184510895\",\"1184510940\",\"1447945214\",\"1447945258\",\"1447959787\",\"1448422676\",\"1448422688\",\"1448422767\",\"1448422855\",\"1448519703\",\"1448522373\",\"1449147619","Genotype 77 is associated with increased risk of Diarrhea when treated with irinotecan in people with Neoplasms as compared to genotype 66.\",\"Genotype 67 is associated with increased risk of Diarrhea when treated with irinotecan in people with Neoplasms as compared to genotype 66.\",\"Genotype 77 is associated with increased risk of Neutropenia when treated with irinotecan in people with Neoplasms as compared to genotypes 66 + 67.\",\"Genotype 77 is associated with increased risk of Neutropenia when treated with irinotecan in people with Neoplasms as compared to genotypes 66 + 67.\",\"Genotypes 67 + 77 are not associated with severity of Neutropenia when treated with irinotecan in people with Neoplasms as compared to genotype 66.\",\"Genotype 77 is associated with increased Neutropenia when treated with irinotecan in people with Colonic Neoplasms as compared to genotype 66.\",\"Genotype 77 is not associated with Drug Toxicity when treated with irinotecan in people with Colonic Neoplasms as compared to genotype 66.\",\"Genotype 77 is not associated with Drug Toxicity when treated with irinotecan in people with Colonic Neoplasms as compared to genotype 66.\",\"Genotype 77 is associated with increased risk of Diarrhea when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are associated with increased Asthenia when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are not associated with Drug Toxicity when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are not associated with Nausea when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes (TA)6/(TA)7 + (TA)7/(TA)7  are not associated with  mucositis when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Genotypes 67 + 77 are not associated with Infection when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are not associated with overall survival when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are associated with increased risk of Diarrhea when treated with irinotecan and raltitrexed in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are associated with increased risk of Vomiting when treated with irinotecan and raltitrexed in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are associated with increased risk of Asthenia when treated with irinotecan and raltitrexed in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are not associated with Neutropenia when treated with irinotecan and raltitrexed in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotype 77 is associated with increased risk of Neutropenia when treated with capecitabine and irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotype 67 is associated with increased Neutropenia when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotype 77 is not associated with Diarrhea when treated with capecitabine and irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are not associated with Diarrhea when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are associated with increased severity of Neutropenia when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are associated with increased Neutropenia when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are associated with increased severity of Diarrhea when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are not associated with progression-free survival when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are not associated with overall survival when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are associated with increased Death when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotype 77 is associated with increased risk of Diarrhea when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotype 77 is not associated with Neutropenia when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotype 67 is not associated with Neutropenia when treated with irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotype 66.\",\"Genotype 67 is not associated with Diarrhea when treated with irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotype 66.\",\"Genotypes 67 + 77 are associated with increased severity of Diarrhea when treated with irinotecan in people with Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are not associated with Neutropenia when treated with irinotecan in people with Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are associated with increased Neutropenia when treated with fluorouracil and irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are not associated with Diarrhea when treated with irinotecan in people with Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are not associated with Neutropenia when treated with irinotecan in people with Neoplasms as compared to genotype 66.\",\"Genotype 67 is not associated with Neutropenia when treated with cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotype 66.\",\"Genotype 67 is not associated with Diarrhea when treated with cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotype 66.\",\"Genotype 77 is not associated with survival when treated with irinotecan in people with Colonic Neoplasms as compared to genotypes 66 + 67.\",\"Genotype 67 is not associated with risk of Diarrhea when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are not associated with Drug Toxicity when treated with irinotecan and raltitrexed in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are not associated with response to irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotypes 67 + 77 are not associated with response to capecitabine and irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotype 67 is not associated with response to irinotecan in people with Colorectal Neoplasms as compared to genotype 66.\",\"Allele 7 is not associated with risk of Drug Toxicity when treated with irinotecan in people with Colorectal Neoplasms.\",\"Genotype 67 is not associated with response to irinotecan in people with Neoplasms as compared to genotype 66.\",\"Genotype 77 is not associated with response to irinotecan in people with Neoplasms as compared to genotype 66.\",\"Genotype (TA)7/(TA)7  is associated with  increased risk of Neutropenia when treated with irinotecan in Colorectal Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Genotype 77 is associated with increased risk of Neutropenia when treated with irinotecan in people with Neoplasms as compared to genotypes 66 + 67.\",\"Allele (TA)7  is associated with  increased likelihood of Drug Toxicity when treated with irinotecan in people with Neoplasms as compared to allele (TA)6.\",\"Genotypes (TA)6/(TA)7 + (TA)7/(TA)7  are associated with  decreased absolute neutrophil count when treated with irinotecan in people with Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Genotype (TA)7/(TA)7  is associated with  increased likelihood of Neutropenia when treated with fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Genotype (TA)6/(TA)6  is associated with  increased likelihood of Neutropenia when treated with fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to genotype (TA)6/(TA)7.\",\"Genotype (TA)7/(TA)7  is associated with  increased likelihood of Neutropenia when treated with fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to genotype (TA)6/(TA)7.\",\"Genotype (TA)6/(TA)6  is associated with  increased likelihood of Neutropenia when treated with fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to genotype (TA)7/(TA)7.\",\"Genotype (TA)7/(TA)7  is not associated with  increased likelihood of Diarrhea when treated with fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to genotypes (TA)6/(TA)6 + (TA)6/(TA)7.\",\"Genotype (TA)7/(TA)7  is not associated with  increased risk of Diarrhea when treated with irinotecan in people with Neoplasms as compared to genotype (TA)6/(TA)7.\",\"Genotype 77 is associated with increased severity of Neutropenia when treated with fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to genotype 66.\",\"Genotype (TA)7/(TA)7  is not associated with  increased risk of Neutropenia when treated with irinotecan in people with Neoplasms as compared to genotype (TA)6/(TA)7.\",\"Genotype (TA)7/(TA)7  is not associated with  increased risk of Neutropenia when treated with irinotecan in people with Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Genotype (TA)7/(TA)7  is not associated with  increased risk of Diarrhea when treated with irinotecan in people with Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Allele 7 is not associated with increased risk of adverse events when treated with irinotecan in people with Neoplasms as compared to genotype 66.\",\"Genotypes (TA)6/(TA)7 + (TA)7/(TA)7  are not associated with  response to irinotecan in people with Colorectal Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Genotype (TA)6/(TA)7  is not associated with  response to cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to genotype (TA)6/(TA)6.\",\"Genotype (TA)6/(TA)7  is associated with  increased risk of Neutropenia when treated with irinotecan in Colorectal Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Genotype (TA)7/(TA)7  is associated with  increased risk of Neutropenia when treated with irinotecan in Colorectal Neoplasms as compared to genotypes (TA)6/(TA)6 + (TA)6/(TA)7.\",\"Genotype (TA)7/(TA)7  is associated with  increased risk of Diarrhea when treated with irinotecan in Colorectal Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Genotype (TA)6/(TA)7  is not associated with  risk of Diarrhea when treated with irinotecan in Colorectal Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Genotype (TA)7/(TA)7  is associated with  increased risk of Diarrhea when treated with irinotecan in Colorectal Neoplasms as compared to genotypes (TA)6/(TA)6 + (TA)6/(TA)7.\",\"Genotype (TA)6/(TA)7  is associated with  increased risk of Diarrhea when treated with irinotecan in people with Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Genotype (TA)6/(TA)7  is not associated with  risk of Drug Toxicity when treated with irinotecan in people with Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Genotypes (TA)6/(TA)7 + (TA)7/(TA)7  is associated with  increased risk of Diarrhea when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Allele (TA)7  is not associated with  risk of Neutropenia when treated with irinotecan in people with Colorectal Neoplasms as compared to allele (TA)6.\",\"Allele (TA)7  is not associated with  response to irinotecan in people with Colorectal Neoplasms as compared to allele (TA)6.\",\"Allele (TA)7  is not associated with  progression-free survival when treated with irinotecan in people with Colorectal Neoplasms as compared to allele (TA)6.\",\"Genotype (TA)7/(TA)7  is not associated with  severity of Drug Toxicity when exposed to capecitabine in people with Colorectal Neoplasms as compared to genotypes (TA)6/(TA)6 + (TA)6/(TA)7.\",\"Genotype (TA)6/(TA)6  is not associated with  risk of Neutropenia when treated with irinotecan in people with biliary tract neoplasms and Pancreatic Neoplasms as compared to genotypes (TA)6/(TA)7 + (TA)7/(TA)7.\",\"Allele (TA)7  is associated with  increased risk of Neutropenia when treated with irinotecan in people with Colorectal Neoplasms as compared to allele (TA)6.\",\"Allele (TA)7  is associated with  increased likelihood of Diarrhea when treated with irinotecan in people with Lung Neoplasms as compared to allele (TA)6.\",\"Allele (TA)7  is not associated with  likelihood of Neutropenia when treated with irinotecan in people with Lung Neoplasms as compared to allele (TA)6.\",\"Genotype (TA)7/(TA)7  is associated with  increased likelihood of Diarrhea when treated with irinotecan in people with Lung Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Genotype (TA)7/(TA)7  is not associated with  likelihood of Neutropenia when treated with irinotecan in people with Lung Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Genotype (TA)7/(TA)7  is associated with  increased severity of Asthenia, Diarrhea and Neutropenia when treated with irinotecan in people with Colorectal Neoplasms as compared to genotype (TA)6/(TA)6.\",\"Allele (TA)7  is associated with  decreased concentrations of UGT1A1 in human liver microsomes as compared to allele (TA)6.\",\"Allele (TA)7  is not associated with  response to irinotecan in people with Lung Neoplasms as compared to allele (TA)6.\",\"UGT1A1 *1/*1  is not associated with  overall survival when treated with irinotecan in people with Neoplasms as compared to UGT1A1 *1/*28 + *28/*28.\",\"UGT1A1 *1/*1  is not associated with  progression-free survival when treated with irinotecan in people with Neoplasms as compared to UGT1A1 *1/*28 + *28/*28.\",\"UGT1A1 *28  is not associated with  risk of Neutropenia when treated with irinotecan in people with Neoplasms.\",\"UGT1A1 *6 + *28  is associated with  risk of Neutropenia when treated with irinotecan in people with Neoplasms.\",\"UGT1A1 *6/*6 + *28/*28 + *6/*28  is associated with  increased risk of Neutropenia when treated with irinotecan in people with Neoplasms as compared to UGT1A1 *1/*6 + *1/*28 + *1/*1.\",\"UGT1A1 *28  is associated with  decreased overall survival when treated with irinotecan, oxaliplatin and s 1 (combination) in people with Colorectal Neoplasms.\",\"UGT1A1 *28  is not associated with  Drug Toxicity when treated with irinotecan, oxaliplatin and s 1 (combination) in people with Colorectal Neoplasms.\",\"UGT1A1 *28  is not associated with  response to irinotecan, oxaliplatin and s 1 (combination) in people with Colorectal Neoplasms.\",\"UGT1A1 *6/*6 + *28/*28 + *6/*28  is associated with  increased risk of Drug Toxicity when treated with irinotecan in people with Neoplasms as compared to UGT1A1 *1/*6 + *1/*28.\",\"UGT1A1 *6/*6 + *28/*28 + *6/*28  is not associated with  risk of Diarrhea when treated with irinotecan in people with Neoplasms as compared to UGT1A1 *1/*6 + *1/*28.\",\"UGT1A1 *1/*28 + *28/*28  is associated with  increased risk of Diarrhea when treated with cisplatin and irinotecan in women with Ovarian Neoplasms as compared to UGT1A1 *1/*1.\",\"UGT1A1 *6 + *28  are associated with  increased risk of Neutropenia when treated with irinotecan in people with Neoplasms.\",\"UGT1A1 *6 + *28  are not associated with  risk of Diarrhea when treated with irinotecan in people with Neoplasms.\",\"UGT1A1 *6 + *28  are associated with  increased risk of Diarrhea when treated with irinotecan in people with Colorectal Neoplasms.\",\"UGT1A1 *1/*28 + *6/*28  are associated with  increased risk of Leukopenia or Neutropenia when treated with irinotecan in people with Lung Neoplasms as compared to UGT1A1 *1/*1.\",\"UGT1A1 *28/*28  is associated with  increased risk of Neutropenia when treated with irinotecan in people with Colorectal Neoplasms as compared to UGT1A1 *1/*1 + *1/*28.\",\"UGT1A1 *28/*28  is not associated with  response to fluorouracil, irinotecan or oxaliplatin in people with Colorectal Neoplasms as compared to UGT1A1 *1/*1 + *1/*28.\",\"UGT1A1 *28/*28  is associated with  Drug Toxicity when treated with irinotecan in women with Rhabdomyosarcoma, Alveolar.","11156391,11990381,15007088,15280927,15297419,16456808,16636344,16951398,17185998,17510208,17549067,17577039,17728214,18221820,18300238,18349289,18594531,18797458,19390945,19450125,20335017,20530282,20562211,22676194,23386248,23529007,23963147,24308720,24519753,24709690,24815493,25285015,25782327,26125934,26229432,26830078,26857783,26862009,27160286,27385990,28367249,28502040,29098099,29504153,29737521","105","irinotecan (PA450085)","Neoplasms (PA445062)","Mixed Population","chr2"]
<#Mapping1>
rr:logicalTable [ rr:sqlQuery """
  select row_number() over (partition by filename) as autor2rml_rownum
    , NULLIF(trim(columns[0]), '') as `ClinicalAnnotationId`
    , NULLIF(trim(columns[1]), '') as `Location`
    , NULLIF(trim(columns[2]), '') as `Gene`
    , NULLIF(trim(columns[3]), '') as `LevelOfEvidence`
    , NULLIF(trim(columns[4]), '') as `ClinicalAnnotationTypes`
    , NULLIF(trim(columns[5]), '') as `GenotypePhenotypeIds`
    , NULLIF(trim(columns[6]), '') as `AnnotationText`
    , NULLIF(trim(columns[7]), '') as `VariantAnnotationsIds`
    , NULLIF(trim(columns[8]), '') as `VariantAnnotations`
    , NULLIF(trim(columns[9]), '') as `Pmids`
    , NULLIF(trim(columns[10]), '') as `EvidenceCount`
    , NULLIF(trim(columns[11]), '') as `RelatedChemicals`
    , NULLIF(trim(columns[12]), '') as `RelatedDiseases`
    , NULLIF(trim(columns[13]), '') as `Race`
    , NULLIF(trim(columns[14]), '') as `Chromosome`
  from dfs.root.`/data/input/pharmgkb/clinical_ann_metadata.tsv`;
"""];
rr:subjectMap [
  rr:termType rr:IRI;
  rr:template "https://w3id.org/data2services/data/input/pharmgkb/clinical_ann_metadata.tsv/{autor2rml_rownum}";
  rr:class <https://w3id.org/data2services/data/input/pharmgkb/clinical_ann_metadata.tsv>;
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/ClinicalAnnotationId>;
  rr:objectMap [ rr:column "ClinicalAnnotationId" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Location>;
  rr:objectMap [ rr:column "Location" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Gene>;
  rr:objectMap [ rr:column "Gene" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/LevelOfEvidence>;
  rr:objectMap [ rr:column "LevelOfEvidence" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/ClinicalAnnotationTypes>;
  rr:objectMap [ rr:column "ClinicalAnnotationTypes" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/GenotypePhenotypeIds>;
  rr:objectMap [ rr:column "GenotypePhenotypeIds" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/AnnotationText>;
  rr:objectMap [ rr:column "AnnotationText" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/VariantAnnotationsIds>;
  rr:objectMap [ rr:column "VariantAnnotationsIds" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/VariantAnnotations>;
  rr:objectMap [ rr:column "VariantAnnotations" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Pmids>;
  rr:objectMap [ rr:column "Pmids" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/EvidenceCount>;
  rr:objectMap [ rr:column "EvidenceCount" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/RelatedChemicals>;
  rr:objectMap [ rr:column "RelatedChemicals" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/RelatedDiseases>;
  rr:objectMap [ rr:column "RelatedDiseases" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Race>;
  rr:objectMap [ rr:column "Race" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Chromosome>;
  rr:objectMap [ rr:column "Chromosome" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
.


# ["Genotype-Phenotype ID","Genotype","Clinical Phenotype"]
# ["1447963976","CC","Patients with genotype CC may have decreased likelihood of drug resistance when treated with antiepileptics and carbamazepine in people with Epilepsy as compared to patients with genotype AA. However, contradictory findings have been reported. Genotype CC is not associated with dose of carbamazepine. Other genetic and clinical factors may also influence a patient's response to carbamazepine."]
# ["1447963993","AA","Male patients with the AA genotype and specifically localization-related epilepsy syndrome may have a decreased risk for resistance to antiepileptic treatment as compared to patients with the GG genotype. However, one study found no association between this variant and resistance to antiepileptic treatment. Other genetic and clinical factors may also influence resistance to antiepileptics."]
<#Mapping2>
rr:logicalTable [ rr:sqlQuery """
  select row_number() over (partition by filename) as autor2rml_rownum
    , NULLIF(trim(columns[0]), '') as `GenotypePhenotypeId`
    , NULLIF(trim(columns[1]), '') as `Genotype`
    , NULLIF(trim(columns[2]), '') as `ClinicalPhenotype`
  from dfs.root.`/data/input/pharmgkb/clinical_ann.tsv`;
"""];
rr:subjectMap [
  rr:termType rr:IRI;
  rr:template "https://w3id.org/data2services/data/input/pharmgkb/clinical_ann.tsv/{autor2rml_rownum}";
  rr:class <https://w3id.org/data2services/data/input/pharmgkb/clinical_ann.tsv>;
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/GenotypePhenotypeId>;
  rr:objectMap [ rr:column "GenotypePhenotypeId" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Genotype>;
  rr:objectMap [ rr:column "Genotype" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/ClinicalPhenotype>;
  rr:objectMap [ rr:column "ClinicalPhenotype" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
.


# ["Entity1_id","Entity1_name","Entity1_type","Entity2_id","Entity2_name","Entity2_type","Evidence","Association","PK","PD","PMIDs"]
# ["PA166181185","CYP2D6*14","Haplotype","PA131301952","gefitinib","Chemical","VariantAnnotation","associated","","PD","26323212"]
# ["PA166181185","CYP2D6*14","Haplotype","PA134688071","atomoxetine","Chemical","GuidelineAnnotation","associated","","",""]
<#Mapping3>
rr:logicalTable [ rr:sqlQuery """
  select row_number() over (partition by filename) as autor2rml_rownum
    , NULLIF(trim(columns[0]), '') as `Entity1_id`
    , NULLIF(trim(columns[1]), '') as `Entity1_name`
    , NULLIF(trim(columns[2]), '') as `Entity1_type`
    , NULLIF(trim(columns[3]), '') as `Entity2_id`
    , NULLIF(trim(columns[4]), '') as `Entity2_name`
    , NULLIF(trim(columns[5]), '') as `Entity2_type`
    , NULLIF(trim(columns[6]), '') as `Evidence`
    , NULLIF(trim(columns[7]), '') as `Association`
    , NULLIF(trim(columns[8]), '') as `Pk`
    , NULLIF(trim(columns[9]), '') as `Pd`
    , NULLIF(trim(columns[10]), '') as `Pmids`
  from dfs.root.`/data/input/pharmgkb/relationships.tsv`;
"""];
rr:subjectMap [
  rr:termType rr:IRI;
  rr:template "https://w3id.org/data2services/data/input/pharmgkb/relationships.tsv/{autor2rml_rownum}";
  rr:class <https://w3id.org/data2services/data/input/pharmgkb/relationships.tsv>;
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Entity1_id>;
  rr:objectMap [ rr:column "Entity1_id" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Entity1_name>;
  rr:objectMap [ rr:column "Entity1_name" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Entity1_type>;
  rr:objectMap [ rr:column "Entity1_type" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Entity2_id>;
  rr:objectMap [ rr:column "Entity2_id" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Entity2_name>;
  rr:objectMap [ rr:column "Entity2_name" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Entity2_type>;
  rr:objectMap [ rr:column "Entity2_type" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Evidence>;
  rr:objectMap [ rr:column "Evidence" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Association>;
  rr:objectMap [ rr:column "Association" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Pk>;
  rr:objectMap [ rr:column "Pk" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Pd>;
  rr:objectMap [ rr:column "Pd" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Pmids>;
  rr:objectMap [ rr:column "Pmids" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
.


# ["Variant ID","Variant Name","Gene IDs","Gene Symbols","Location","Variant Annotation count","Clinical Annotation count","Level 1/2 Clinical Annotation count","Guideline Annotation count","Label Annotation count","Synonyms"]
# ["PA166156302","rs1000002","PA395","ABCC5","NC_000003.11:183635768","1","0","0","0","0","rs17623022, NC_000003.12:g.183917980C>T, rs386508637, rs1000002, 1000002, [GRCh37]chr3:183635768, rs60664316, NC_000003.11:g.183635768C>T"]
# ["PA166156746","rs1000113","","","NC_000005.9:150240076","1","0","0","0","0","1000113, [GRCh37]chr5:150240076, NC_000005.9:g.150240076C>T, rs1000113, rs58108943, NC_000005.10:g.150860514C>T, XM_011537641.1:c.531+11860C>T"]
<#Mapping4>
rr:logicalTable [ rr:sqlQuery """
  select row_number() over (partition by filename) as autor2rml_rownum
    , NULLIF(trim(columns[0]), '') as `VariantId`
    , NULLIF(trim(columns[1]), '') as `VariantName`
    , NULLIF(trim(columns[2]), '') as `GeneIds`
    , NULLIF(trim(columns[3]), '') as `GeneSymbols`
    , NULLIF(trim(columns[4]), '') as `Location`
    , NULLIF(trim(columns[5]), '') as `VariantAnnotationCount`
    , NULLIF(trim(columns[6]), '') as `ClinicalAnnotationCount`
    , NULLIF(trim(columns[7]), '') as `Level1/2ClinicalAnnotationCount`
    , NULLIF(trim(columns[8]), '') as `GuidelineAnnotationCount`
    , NULLIF(trim(columns[9]), '') as `LabelAnnotationCount`
    , NULLIF(trim(columns[10]), '') as `Synonyms`
  from dfs.root.`/data/input/pharmgkb/variants.tsv`;
"""];
rr:subjectMap [
  rr:termType rr:IRI;
  rr:template "https://w3id.org/data2services/data/input/pharmgkb/variants.tsv/{autor2rml_rownum}";
  rr:class <https://w3id.org/data2services/data/input/pharmgkb/variants.tsv>;
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/VariantId>;
  rr:objectMap [ rr:column "VariantId" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/VariantName>;
  rr:objectMap [ rr:column "VariantName" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/GeneIds>;
  rr:objectMap [ rr:column "GeneIds" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/GeneSymbols>;
  rr:objectMap [ rr:column "GeneSymbols" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Location>;
  rr:objectMap [ rr:column "Location" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/VariantAnnotationCount>;
  rr:objectMap [ rr:column "VariantAnnotationCount" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/ClinicalAnnotationCount>;
  rr:objectMap [ rr:column "ClinicalAnnotationCount" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Level1/2ClinicalAnnotationCount>;
  rr:objectMap [ rr:column "Level1/2ClinicalAnnotationCount" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/GuidelineAnnotationCount>;
  rr:objectMap [ rr:column "GuidelineAnnotationCount" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/LabelAnnotationCount>;
  rr:objectMap [ rr:column "LabelAnnotationCount" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Synonyms>;
  rr:objectMap [ rr:column "Synonyms" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
.


# ["PharmGKB Accession Id","Name","Alternate Names","Cross-references","External Vocabulary"]
# ["PA165108557","11q partial monosomy syndrome","","","MeSH:D054868(Jacobsen Distal 11q Deletion Syndrome)\",\"SnoMedCT:4325000(11q partial monosomy syndrome)\",\"UMLS:C0795841(C0795841)\",\"NDFRT:N0000181176(Jacobsen Distal 11q Deletion Syndrome [Disease/Finding])"]
# ["PA128406957","5-fluorouracil associated toxicity","","",""]
<#Mapping5>
rr:logicalTable [ rr:sqlQuery """
  select row_number() over (partition by filename) as autor2rml_rownum
    , NULLIF(trim(columns[0]), '') as `PharmgkbAccessionId`
    , NULLIF(trim(columns[1]), '') as `Name`
    , NULLIF(trim(columns[2]), '') as `AlternateNames`
    , NULLIF(trim(columns[3]), '') as `CrossReferences`
    , NULLIF(trim(columns[4]), '') as `ExternalVocabulary`
  from dfs.root.`/data/input/pharmgkb/phenotypes.tsv`;
"""];
rr:subjectMap [
  rr:termType rr:IRI;
  rr:template "https://w3id.org/data2services/data/input/pharmgkb/phenotypes.tsv/{autor2rml_rownum}";
  rr:class <https://w3id.org/data2services/data/input/pharmgkb/phenotypes.tsv>;
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/PharmgkbAccessionId>;
  rr:objectMap [ rr:column "PharmgkbAccessionId" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Name>;
  rr:objectMap [ rr:column "Name" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/AlternateNames>;
  rr:objectMap [ rr:column "AlternateNames" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/CrossReferences>;
  rr:objectMap [ rr:column "CrossReferences" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/ExternalVocabulary>;
  rr:objectMap [ rr:column "ExternalVocabulary" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
.


# ["Annotation ID","Variant","Gene","Chemical","PMID","Phenotype Category","Significance","Notes","Sentence","StudyParameters","Alleles","Chromosome"]
# ["1449191113","rs141033578","CFTR (PA109)","ivacaftor (PA165950341)","23891399","efficacy","yes","S977F allele. 3.8 fold increase in chloride transport upon ivacaftor treatment as compared to baseline (no ivacaftor treatment).","Allele T is associated with activity of CFTR when treated with ivacaftor in FRT cell lines.","1449191115","T","chr7"]
# ["981240145","rs4646244","NAT2 (PA18)","","19891553","other","yes","","Allele A is associated with decreased transcription of NAT2 (as determined in luciferase reporter assays) as compared to allele T.","981240150","A","chr8"]
<#Mapping6>
rr:logicalTable [ rr:sqlQuery """
  select row_number() over (partition by filename) as autor2rml_rownum
    , NULLIF(trim(columns[0]), '') as `AnnotationId`
    , NULLIF(trim(columns[1]), '') as `Variant`
    , NULLIF(trim(columns[2]), '') as `Gene`
    , NULLIF(trim(columns[3]), '') as `Chemical`
    , NULLIF(trim(columns[4]), '') as `Pmid`
    , NULLIF(trim(columns[5]), '') as `PhenotypeCategory`
    , NULLIF(trim(columns[6]), '') as `Significance`
    , NULLIF(trim(columns[7]), '') as `Notes`
    , NULLIF(trim(columns[8]), '') as `Sentence`
    , NULLIF(trim(columns[9]), '') as `Studyparameters`
    , NULLIF(trim(columns[10]), '') as `Alleles`
    , NULLIF(trim(columns[11]), '') as `Chromosome`
  from dfs.root.`/data/input/pharmgkb/var_fa_ann.tsv`;
"""];
rr:subjectMap [
  rr:termType rr:IRI;
  rr:template "https://w3id.org/data2services/data/input/pharmgkb/var_fa_ann.tsv/{autor2rml_rownum}";
  rr:class <https://w3id.org/data2services/data/input/pharmgkb/var_fa_ann.tsv>;
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/AnnotationId>;
  rr:objectMap [ rr:column "AnnotationId" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Variant>;
  rr:objectMap [ rr:column "Variant" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Gene>;
  rr:objectMap [ rr:column "Gene" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Chemical>;
  rr:objectMap [ rr:column "Chemical" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Pmid>;
  rr:objectMap [ rr:column "Pmid" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/PhenotypeCategory>;
  rr:objectMap [ rr:column "PhenotypeCategory" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Significance>;
  rr:objectMap [ rr:column "Significance" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Notes>;
  rr:objectMap [ rr:column "Notes" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Sentence>;
  rr:objectMap [ rr:column "Sentence" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Studyparameters>;
  rr:objectMap [ rr:column "Studyparameters" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Alleles>;
  rr:objectMap [ rr:column "Alleles" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Chromosome>;
  rr:objectMap [ rr:column "Chromosome" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
.


# ["variant","gene","type","level of evidence","chemicals","phenotypes"]
# ["rs4986893","CYP2C19","Efficacy,Toxicity/ADR","1A","clopidogrel","Acute coronary syndrome,Coronary Artery Disease"]
# ["CYP2C19*1, CYP2C19*2, CYP2C19*3","CYP2C19","Metabolism/PK","1A","sertraline","Depressive Disorder, Major"]
<#Mapping7>
rr:logicalTable [ rr:sqlQuery """
  select row_number() over (partition by filename) as autor2rml_rownum
    , NULLIF(trim(columns[0]), '') as `Variant`
    , NULLIF(trim(columns[1]), '') as `Gene`
    , NULLIF(trim(columns[2]), '') as `Type`
    , NULLIF(trim(columns[3]), '') as `LevelOfEvidence`
    , NULLIF(trim(columns[4]), '') as `Chemicals`
    , NULLIF(trim(columns[5]), '') as `Phenotypes`
  from dfs.root.`/data/input/pharmgkb/clinicalVariants.tsv`;
"""];
rr:subjectMap [
  rr:termType rr:IRI;
  rr:template "https://w3id.org/data2services/data/input/pharmgkb/clinicalVariants.tsv/{autor2rml_rownum}";
  rr:class <https://w3id.org/data2services/data/input/pharmgkb/clinicalVariants.tsv>;
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Variant>;
  rr:objectMap [ rr:column "Variant" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Gene>;
  rr:objectMap [ rr:column "Gene" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Type>;
  rr:objectMap [ rr:column "Type" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/LevelOfEvidence>;
  rr:objectMap [ rr:column "LevelOfEvidence" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Chemicals>;
  rr:objectMap [ rr:column "Chemicals" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Phenotypes>;
  rr:objectMap [ rr:column "Phenotypes" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
.


# ["PharmGKB.Accession.Id","NCBI.Gene.ID","HGNC.ID","Ensembl.Id","Name","Symbol","Alternate.Names","Alternate.Symbols","Is.VIP","Has.Variant.Annotation","Cross.references","Has.CPIC.Dosing.Guideline","Chromosome","Chromosomal.Start...GRCh37.p13","Chromosomal.Stop...GRCh37.p13","Chromosomal.Start...GRCh38.p7","Chromosomal.Stop...GRCh38.p7"]
# ["PA24356","1","5","ENSG00000121410","alpha-1-B glycoprotein","A1BG","NA","NA","No","No","ALFRED:LO098153A,Comparative Toxicogenomics Database:1,Ensembl:ENSG00000121410,GenAtlas:A1BG,GeneCard:A1BG,GO:GO:0000004,GO:GO:0005554,GO:GO:0005576,HGNC:5,HumanCyc Gene:HS04495,ModBase:P04217,MutDB:A1BG,NCBI Gene:1,OMIM:138670,RefSeq DNA:NT_011109,RefSeq Protein:NP_570602,RefSeq RNA:NM_130786,UCSC Genome Browser:NM_130786,UniProtKB:P04217","No","chr19","58858172","58864865","58346806","58353499"]
# ["PA165392995","503538","37133","NA","A1BG antisense RNA 1","A1BG-AS1","NA","FLJ23569","No","No","GeneCard:A1BG-AS1,HGNC:37133,NCBI Gene:503538,RefSeq DNA:NT_011109,RefSeq RNA:NR_015380","No","chr19","58863336","58866549","58351970","58355183"]
<#Mapping8>
rr:logicalTable [ rr:sqlQuery """
  select row_number() over (partition by filename) as autor2rml_rownum
    , NULLIF(trim(columns[0]), '') as `Pharmgkb.accession.id`
    , NULLIF(trim(columns[1]), '') as `Ncbi.gene.id`
    , NULLIF(trim(columns[2]), '') as `Hgnc.id`
    , NULLIF(trim(columns[3]), '') as `Ensembl.id`
    , NULLIF(trim(columns[4]), '') as `Name`
    , NULLIF(trim(columns[5]), '') as `Symbol`
    , NULLIF(trim(columns[6]), '') as `Alternate.names`
    , NULLIF(trim(columns[7]), '') as `Alternate.symbols`
    , NULLIF(trim(columns[8]), '') as `Is.vip`
    , NULLIF(trim(columns[9]), '') as `Has.variant.annotation`
    , NULLIF(trim(columns[10]), '') as `Cross.references`
    , NULLIF(trim(columns[11]), '') as `Has.cpic.dosing.guideline`
    , NULLIF(trim(columns[12]), '') as `Chromosome`
    , NULLIF(trim(columns[13]), '') as `Chromosomal.start...grch37.p13`
    , NULLIF(trim(columns[14]), '') as `Chromosomal.stop...grch37.p13`
    , NULLIF(trim(columns[15]), '') as `Chromosomal.start...grch38.p7`
    , NULLIF(trim(columns[16]), '') as `Chromosomal.stop...grch38.p7`
  from dfs.root.`/data/input/pharmgkb/genes.csv`;
"""];
rr:subjectMap [
  rr:termType rr:IRI;
  rr:template "https://w3id.org/data2services/data/input/pharmgkb/genes.csv/{autor2rml_rownum}";
  rr:class <https://w3id.org/data2services/data/input/pharmgkb/genes.csv>;
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Pharmgkb.accession.id>;
  rr:objectMap [ rr:column "Pharmgkb.accession.id" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Ncbi.gene.id>;
  rr:objectMap [ rr:column "Ncbi.gene.id" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Hgnc.id>;
  rr:objectMap [ rr:column "Hgnc.id" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Ensembl.id>;
  rr:objectMap [ rr:column "Ensembl.id" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Name>;
  rr:objectMap [ rr:column "Name" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Symbol>;
  rr:objectMap [ rr:column "Symbol" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Alternate.names>;
  rr:objectMap [ rr:column "Alternate.names" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Alternate.symbols>;
  rr:objectMap [ rr:column "Alternate.symbols" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Is.vip>;
  rr:objectMap [ rr:column "Is.vip" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Has.variant.annotation>;
  rr:objectMap [ rr:column "Has.variant.annotation" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Cross.references>;
  rr:objectMap [ rr:column "Cross.references" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Has.cpic.dosing.guideline>;
  rr:objectMap [ rr:column "Has.cpic.dosing.guideline" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Chromosome>;
  rr:objectMap [ rr:column "Chromosome" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Chromosomal.start...grch37.p13>;
  rr:objectMap [ rr:column "Chromosomal.start...grch37.p13" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Chromosomal.stop...grch37.p13>;
  rr:objectMap [ rr:column "Chromosomal.stop...grch37.p13" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Chromosomal.start...grch38.p7>;
  rr:objectMap [ rr:column "Chromosomal.start...grch38.p7" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Chromosomal.stop...grch38.p7>;
  rr:objectMap [ rr:column "Chromosomal.stop...grch38.p7" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
.


# ["Annotation ID","Variant","Gene","Chemical","PMID","Phenotype Category","Significance","Notes","Sentence","StudyParameters","Alleles","Chromosome"]
# ["608431768","rs1131873","EPHX1 (PA27829)","warfarin (PA451906)","19794411","dosage","yes","","Allele A is associated with decreased dose of warfarin.","608431770","A","chr1"]
# ["827690618","rs1131873","EPHX1 (PA27829)","warfarin (PA451906)","21593757","dosage","no","in italian patients.","Allele A is not associated with dose of warfarin.","827690625","A","chr1"]
<#Mapping9>
rr:logicalTable [ rr:sqlQuery """
  select row_number() over (partition by filename) as autor2rml_rownum
    , NULLIF(trim(columns[0]), '') as `AnnotationId`
    , NULLIF(trim(columns[1]), '') as `Variant`
    , NULLIF(trim(columns[2]), '') as `Gene`
    , NULLIF(trim(columns[3]), '') as `Chemical`
    , NULLIF(trim(columns[4]), '') as `Pmid`
    , NULLIF(trim(columns[5]), '') as `PhenotypeCategory`
    , NULLIF(trim(columns[6]), '') as `Significance`
    , NULLIF(trim(columns[7]), '') as `Notes`
    , NULLIF(trim(columns[8]), '') as `Sentence`
    , NULLIF(trim(columns[9]), '') as `Studyparameters`
    , NULLIF(trim(columns[10]), '') as `Alleles`
    , NULLIF(trim(columns[11]), '') as `Chromosome`
  from dfs.root.`/data/input/pharmgkb/var_drug_ann.tsv`;
"""];
rr:subjectMap [
  rr:termType rr:IRI;
  rr:template "https://w3id.org/data2services/data/input/pharmgkb/var_drug_ann.tsv/{autor2rml_rownum}";
  rr:class <https://w3id.org/data2services/data/input/pharmgkb/var_drug_ann.tsv>;
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/AnnotationId>;
  rr:objectMap [ rr:column "AnnotationId" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Variant>;
  rr:objectMap [ rr:column "Variant" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Gene>;
  rr:objectMap [ rr:column "Gene" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Chemical>;
  rr:objectMap [ rr:column "Chemical" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Pmid>;
  rr:objectMap [ rr:column "Pmid" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/PhenotypeCategory>;
  rr:objectMap [ rr:column "PhenotypeCategory" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Significance>;
  rr:objectMap [ rr:column "Significance" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Notes>;
  rr:objectMap [ rr:column "Notes" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Sentence>;
  rr:objectMap [ rr:column "Sentence" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Studyparameters>;
  rr:objectMap [ rr:column "Studyparameters" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Alleles>;
  rr:objectMap [ rr:column "Alleles" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Chromosome>;
  rr:objectMap [ rr:column "Chromosome" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
.


# ["PharmGKB Accession Id","Name","Generic Names","Trade Names","Brand Mixtures","Type","Cross-references","SMILES","InChI","Dosing Guideline","External Vocabulary","Clinical Annotation Count","Variant Annotation Count","Pathway Count","VIP Count","Dosing Guideline Sources","Top Clinical Annotation Level","Top FDA Label Testing Level","Top Any Drug Label Testing Level","Label Has Dosing Info","Has Rx Annotation","RxNorm Identifiers","ATC Identifiers","PubChem Compound Identifiers"]
# ["PA166131343","(-)-carbovir 5'-diphosphate","","","","Metabolite","PubChem Compound:135564825","C1[C@@H](C=C[C@@H]1N2C=NC3=C2NC(=NC3=O)N)COP(=O)(O)OP(=O)(O)O","InChI=1S/C11H15N5O8P2/c12-11-14-9-8(10(17)15-11)13-5-16(9)7-2-1-6(3-7)4-23-26(21,22)24-25(18,19)20/h1-2,5-7H,3-4H2,(H,21,22)(H2,18,19,20)(H3,12,14,15,17)/t6-,7+/m1/s1","No","","0","0","0","0","","","","","","","","","135564825"]
# ["PA166178312","(R)-methadone","levomethadone","","","Metabolite","PubChem Compound:22267","","","No","","1","0","0","0","","3","","","","","","","22267"]
<#Mapping10>
rr:logicalTable [ rr:sqlQuery """
  select row_number() over (partition by filename) as autor2rml_rownum
    , NULLIF(trim(columns[0]), '') as `PharmgkbAccessionId`
    , NULLIF(trim(columns[1]), '') as `Name`
    , NULLIF(trim(columns[2]), '') as `GenericNames`
    , NULLIF(trim(columns[3]), '') as `TradeNames`
    , NULLIF(trim(columns[4]), '') as `BrandMixtures`
    , NULLIF(trim(columns[5]), '') as `Type`
    , NULLIF(trim(columns[6]), '') as `CrossReferences`
    , NULLIF(trim(columns[7]), '') as `Smiles`
    , NULLIF(trim(columns[8]), '') as `Inchi`
    , NULLIF(trim(columns[9]), '') as `DosingGuideline`
    , NULLIF(trim(columns[10]), '') as `ExternalVocabulary`
    , NULLIF(trim(columns[11]), '') as `ClinicalAnnotationCount`
    , NULLIF(trim(columns[12]), '') as `VariantAnnotationCount`
    , NULLIF(trim(columns[13]), '') as `PathwayCount`
    , NULLIF(trim(columns[14]), '') as `VipCount`
    , NULLIF(trim(columns[15]), '') as `DosingGuidelineSources`
    , NULLIF(trim(columns[16]), '') as `TopClinicalAnnotationLevel`
    , NULLIF(trim(columns[17]), '') as `TopFdaLabelTestingLevel`
    , NULLIF(trim(columns[18]), '') as `TopAnyDrugLabelTestingLevel`
    , NULLIF(trim(columns[19]), '') as `LabelHasDosingInfo`
    , NULLIF(trim(columns[20]), '') as `HasRxAnnotation`
    , NULLIF(trim(columns[21]), '') as `RxnormIdentifiers`
    , NULLIF(trim(columns[22]), '') as `AtcIdentifiers`
    , NULLIF(trim(columns[23]), '') as `PubchemCompoundIdentifiers`
  from dfs.root.`/data/input/pharmgkb/chemicals.tsv`;
"""];
rr:subjectMap [
  rr:termType rr:IRI;
  rr:template "https://w3id.org/data2services/data/input/pharmgkb/chemicals.tsv/{autor2rml_rownum}";
  rr:class <https://w3id.org/data2services/data/input/pharmgkb/chemicals.tsv>;
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/PharmgkbAccessionId>;
  rr:objectMap [ rr:column "PharmgkbAccessionId" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Name>;
  rr:objectMap [ rr:column "Name" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/GenericNames>;
  rr:objectMap [ rr:column "GenericNames" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/TradeNames>;
  rr:objectMap [ rr:column "TradeNames" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/BrandMixtures>;
  rr:objectMap [ rr:column "BrandMixtures" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Type>;
  rr:objectMap [ rr:column "Type" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/CrossReferences>;
  rr:objectMap [ rr:column "CrossReferences" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Smiles>;
  rr:objectMap [ rr:column "Smiles" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Inchi>;
  rr:objectMap [ rr:column "Inchi" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/DosingGuideline>;
  rr:objectMap [ rr:column "DosingGuideline" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/ExternalVocabulary>;
  rr:objectMap [ rr:column "ExternalVocabulary" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/ClinicalAnnotationCount>;
  rr:objectMap [ rr:column "ClinicalAnnotationCount" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/VariantAnnotationCount>;
  rr:objectMap [ rr:column "VariantAnnotationCount" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/PathwayCount>;
  rr:objectMap [ rr:column "PathwayCount" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/VipCount>;
  rr:objectMap [ rr:column "VipCount" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/DosingGuidelineSources>;
  rr:objectMap [ rr:column "DosingGuidelineSources" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/TopClinicalAnnotationLevel>;
  rr:objectMap [ rr:column "TopClinicalAnnotationLevel" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/TopFdaLabelTestingLevel>;
  rr:objectMap [ rr:column "TopFdaLabelTestingLevel" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/TopAnyDrugLabelTestingLevel>;
  rr:objectMap [ rr:column "TopAnyDrugLabelTestingLevel" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/LabelHasDosingInfo>;
  rr:objectMap [ rr:column "LabelHasDosingInfo" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/HasRxAnnotation>;
  rr:objectMap [ rr:column "HasRxAnnotation" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/RxnormIdentifiers>;
  rr:objectMap [ rr:column "RxnormIdentifiers" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/AtcIdentifiers>;
  rr:objectMap [ rr:column "AtcIdentifiers" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/PubchemCompoundIdentifiers>;
  rr:objectMap [ rr:column "PubchemCompoundIdentifiers" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
.


# ["Annotation ID","Variant","Gene","Chemical","PMID","Phenotype Category","Significance","Notes","Sentence","StudyParameters","Alleles","Chromosome"]
# ["637879861","rs5760410","ADORA2A (PA24584)\",\"SPECC1L (PA164718673)","methotrexate (PA450428)","18539621","toxicity","yes","","Allele G is associated with increased risk of adverse events when treated with methotrexate in people with Arthritis, Rheumatoid as compared to allele A.","637879863","G","chr22"]
# ["637879888","rs1042522","TP53 (PA36679)","fluorouracil (PA128406956)","18357466","efficacy","yes","This G/C snp is in TP53 which is on the minus strand, presenting the opportunity for the alleles to be easily confused. The C>G change in the gene is represented by a G>C change on the positive chromosomal strand.","Genotype GG is associated with decreased overall survival when treated with fluorouracil in people with Stomach Neoplasms as compared to genotypes CC + CG.","637879891","GG","chr17"]
<#Mapping11>
rr:logicalTable [ rr:sqlQuery """
  select row_number() over (partition by filename) as autor2rml_rownum
    , NULLIF(trim(columns[0]), '') as `AnnotationId`
    , NULLIF(trim(columns[1]), '') as `Variant`
    , NULLIF(trim(columns[2]), '') as `Gene`
    , NULLIF(trim(columns[3]), '') as `Chemical`
    , NULLIF(trim(columns[4]), '') as `Pmid`
    , NULLIF(trim(columns[5]), '') as `PhenotypeCategory`
    , NULLIF(trim(columns[6]), '') as `Significance`
    , NULLIF(trim(columns[7]), '') as `Notes`
    , NULLIF(trim(columns[8]), '') as `Sentence`
    , NULLIF(trim(columns[9]), '') as `Studyparameters`
    , NULLIF(trim(columns[10]), '') as `Alleles`
    , NULLIF(trim(columns[11]), '') as `Chromosome`
  from dfs.root.`/data/input/pharmgkb/var_pheno_ann.tsv`;
"""];
rr:subjectMap [
  rr:termType rr:IRI;
  rr:template "https://w3id.org/data2services/data/input/pharmgkb/var_pheno_ann.tsv/{autor2rml_rownum}";
  rr:class <https://w3id.org/data2services/data/input/pharmgkb/var_pheno_ann.tsv>;
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/AnnotationId>;
  rr:objectMap [ rr:column "AnnotationId" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Variant>;
  rr:objectMap [ rr:column "Variant" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Gene>;
  rr:objectMap [ rr:column "Gene" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Chemical>;
  rr:objectMap [ rr:column "Chemical" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Pmid>;
  rr:objectMap [ rr:column "Pmid" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/PhenotypeCategory>;
  rr:objectMap [ rr:column "PhenotypeCategory" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Significance>;
  rr:objectMap [ rr:column "Significance" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Notes>;
  rr:objectMap [ rr:column "Notes" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Sentence>;
  rr:objectMap [ rr:column "Sentence" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Studyparameters>;
  rr:objectMap [ rr:column "Studyparameters" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Alleles>;
  rr:objectMap [ rr:column "Alleles" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Chromosome>;
  rr:objectMap [ rr:column "Chromosome" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
.


# ["PharmGKB Accession Id","Name","Generic Names","Trade Names","Brand Mixtures","Type","Cross-references","SMILES","InChI","Dosing Guideline","External Vocabulary","Clinical Annotation Count","Variant Annotation Count","Pathway Count","VIP Count","Dosing Guideline Sources","Top Clinical Annotation Level","Top FDA Label Testing Level","Top Any Drug Label Testing Level","Label Has Dosing Info","Has Rx Annotation","RxNorm Identifiers","ATC Identifiers","PubChem Compound Identifiers"]
# ["PA166178554","(S)-methadone","","","","Drug","PubChem Compound:643985","","","No","","0","0","0","0","","","","","","","","","643985"]
# ["PA164712302","2-amino-1-phenylethanol derivatives","","","","Drug Class","","","","No","ATC:C04AA(2-amino-1-phenylethanol derivatives)","0","0","0","0","","","","","","","","C04AA",""]
<#Mapping12>
rr:logicalTable [ rr:sqlQuery """
  select row_number() over (partition by filename) as autor2rml_rownum
    , NULLIF(trim(columns[0]), '') as `PharmgkbAccessionId`
    , NULLIF(trim(columns[1]), '') as `Name`
    , NULLIF(trim(columns[2]), '') as `GenericNames`
    , NULLIF(trim(columns[3]), '') as `TradeNames`
    , NULLIF(trim(columns[4]), '') as `BrandMixtures`
    , NULLIF(trim(columns[5]), '') as `Type`
    , NULLIF(trim(columns[6]), '') as `CrossReferences`
    , NULLIF(trim(columns[7]), '') as `Smiles`
    , NULLIF(trim(columns[8]), '') as `Inchi`
    , NULLIF(trim(columns[9]), '') as `DosingGuideline`
    , NULLIF(trim(columns[10]), '') as `ExternalVocabulary`
    , NULLIF(trim(columns[11]), '') as `ClinicalAnnotationCount`
    , NULLIF(trim(columns[12]), '') as `VariantAnnotationCount`
    , NULLIF(trim(columns[13]), '') as `PathwayCount`
    , NULLIF(trim(columns[14]), '') as `VipCount`
    , NULLIF(trim(columns[15]), '') as `DosingGuidelineSources`
    , NULLIF(trim(columns[16]), '') as `TopClinicalAnnotationLevel`
    , NULLIF(trim(columns[17]), '') as `TopFdaLabelTestingLevel`
    , NULLIF(trim(columns[18]), '') as `TopAnyDrugLabelTestingLevel`
    , NULLIF(trim(columns[19]), '') as `LabelHasDosingInfo`
    , NULLIF(trim(columns[20]), '') as `HasRxAnnotation`
    , NULLIF(trim(columns[21]), '') as `RxnormIdentifiers`
    , NULLIF(trim(columns[22]), '') as `AtcIdentifiers`
    , NULLIF(trim(columns[23]), '') as `PubchemCompoundIdentifiers`
  from dfs.root.`/data/input/pharmgkb/drugs.tsv`;
"""];
rr:subjectMap [
  rr:termType rr:IRI;
  rr:template "https://w3id.org/data2services/data/input/pharmgkb/drugs.tsv/{autor2rml_rownum}";
  rr:class <https://w3id.org/data2services/data/input/pharmgkb/drugs.tsv>;
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/PharmgkbAccessionId>;
  rr:objectMap [ rr:column "PharmgkbAccessionId" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Name>;
  rr:objectMap [ rr:column "Name" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/GenericNames>;
  rr:objectMap [ rr:column "GenericNames" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/TradeNames>;
  rr:objectMap [ rr:column "TradeNames" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/BrandMixtures>;
  rr:objectMap [ rr:column "BrandMixtures" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Type>;
  rr:objectMap [ rr:column "Type" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/CrossReferences>;
  rr:objectMap [ rr:column "CrossReferences" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Smiles>;
  rr:objectMap [ rr:column "Smiles" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/Inchi>;
  rr:objectMap [ rr:column "Inchi" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/DosingGuideline>;
  rr:objectMap [ rr:column "DosingGuideline" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/ExternalVocabulary>;
  rr:objectMap [ rr:column "ExternalVocabulary" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/ClinicalAnnotationCount>;
  rr:objectMap [ rr:column "ClinicalAnnotationCount" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/VariantAnnotationCount>;
  rr:objectMap [ rr:column "VariantAnnotationCount" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/PathwayCount>;
  rr:objectMap [ rr:column "PathwayCount" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/VipCount>;
  rr:objectMap [ rr:column "VipCount" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/DosingGuidelineSources>;
  rr:objectMap [ rr:column "DosingGuidelineSources" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/TopClinicalAnnotationLevel>;
  rr:objectMap [ rr:column "TopClinicalAnnotationLevel" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/TopFdaLabelTestingLevel>;
  rr:objectMap [ rr:column "TopFdaLabelTestingLevel" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/TopAnyDrugLabelTestingLevel>;
  rr:objectMap [ rr:column "TopAnyDrugLabelTestingLevel" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/LabelHasDosingInfo>;
  rr:objectMap [ rr:column "LabelHasDosingInfo" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/HasRxAnnotation>;
  rr:objectMap [ rr:column "HasRxAnnotation" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/RxnormIdentifiers>;
  rr:objectMap [ rr:column "RxnormIdentifiers" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/AtcIdentifiers>;
  rr:objectMap [ rr:column "AtcIdentifiers" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
rr:predicateObjectMap [
  rr:predicate <https://w3id.org/data2services/model/PubchemCompoundIdentifiers>;
  rr:objectMap [ rr:column "PubchemCompoundIdentifiers" ];
  rr:graph <https://w3id.org/data2services/graph/autor2rml>;
];
.


